Skip to main content

Table 1 Key application features of proteomics technologies for cancer liquid biopsies

From: Proteomics technologies for cancer liquid biopsies

 

Basic principles

Typical multi-plexity

Typical sample throughput (per assay)

Limit of Detection/

Dynamic range

Readout

De-novo/

targeted

Laboratory procedures

Advantages

Limitations

Mass Spec (MS)

Samples are prepared according to specific purposes, followed by digestion, peptide ionization, and tandem MS scans.

~ 6500 (Urine)

~ 1500 (blood)

Up to 16 (TMT labelling)

Picogram/

4-5 logs

Fragmented peptide sequences and spectrum counting

De-novo/

Targeted

Heavy instrumentation and non-standardized workflows for pre-MS sample preparation

Semi-automated

De-novo process suitable for exploratory research

Low throughput, Complex depletion process, limitations to analyze protein PTMs

Antibody/Antigen Arrays

Antibodies/Antigens immobilized onto the solid substrates. Targets proteins in samples captured by the antibodies/antigens.

~ 4000 (antibody arrays)/ up ~ 21,000 (antigen arrays)

~ 1-64

Low picogram/

5 logs

Colorimetric assays or fluorescence

Targeted

Standardized workflows, Semi-automated

Widely adopted approach with flexible experimental design and PTM profiling.

Limit on inter-assay reproducibility and quantification, inter-assay variation, Sample labelling

Aptamer-based Assay

Short single-strand DNA or RNA fold into specific tertiary structures with the ability to bind targets with high affinity and specificity.

~ 7000

Up to 1000

Low picogram/

4-5 logs

DNA microarray/ fluorescence

Targeted

Standardized workflows performed at service centers, Semi-automated

High-plexity

Limit on protein PTMs detection; Dependence on DNA microarray for readout

Proximity extension assay (PEA)

Sandwich ELISA labeled with complementary DNA oligos binds to the target allowing the oligos to hybridized.

~ 3000

88

Low picogram to femtogram/

10 logs

qPCR (medium-plex) or NGS (high-plex)

Targeted

Standardized workflows with Semi-automated

Very little sample required with large dynamic ranges

Dependence on Q-PCR/NGS for readout

Reverse phase protein arrays (RPPA)

Protein samples immobilized onto the solid substrates. Targets detected by antibodies with signal amplification.

~ 500

Up to 1056

Femtogram/

5-6 logs

Colorimetric assays or

fluorescence

Targeted

Heavy instrumentation and non-standardized workflows, Semi-automated

Large scale parallel analysis for samples. Suitable for protein PTMs

Relatively long turnaround time